intellectual property
Broad Wins CRISPR Patent Interference Case
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
Notable Science Quotes
Notable Science Quotes
The Scientist Staff | Feb 1, 2017
Intellectual property theft, gun violence, scientific failure, and more
Infographic: Repurposing Strategies
Infographic: Repurposing Strategies
Anna Azvolinsky | Dec 31, 2016
Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.
Life Science Controversies of 2016
Life Science Controversies of 2016
Bob Grant, Jef Akst, Tracy Vence | Dec 23, 2016
This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.
Video: Patent Battle Over CRISPR Gene Editing
Video: Patent Battle Over CRISPR Gene Editing
Jef Akst | Dec 13, 2016
The Scientist goes to court for a CRISPR patent interference case at the US Patent and Trademark Office.
New Developments in CRISPR Patent Case
New Developments in CRISPR Patent Case
Jef Akst | Dec 12, 2016
Documents suggest Feng Zhang started working on CRISPR before Jennifer Doudna’s group published; researchers call for CRISPR technology to be shared openly
CRISPR Oral Arguments Recap, Cont’d
CRISPR Oral Arguments Recap, Cont’d
Jef Akst | Dec 8, 2016
This week’s CRISPR patent hearing took a deep dive into the science of moving the gene-editing technology from prokaryotes to eukaryotic systems.
USPTO to Hear Arguments on CRISPR Patents
USPTO to Hear Arguments on CRISPR Patents
Jef Akst | Dec 5, 2016
Tuesday morning, the US Patent and Trademark Office will hear oral arguments from the two parties that claim to have been the first to use CRISPR-Cas9 gene editing technology in eukaryotic cells.
Week in Review: August 29–September 2
Week in Review: August 29–September 2
Jef Akst | Sep 2, 2016
Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer
Student Alleges His Team Didn’t Earn CRISPR Patent
Student Alleges His Team Didn’t Earn CRISPR Patent
Kerry Grens | Aug 18, 2016
A former researcher at the Broad Institute has suggested the University of California, Berkeley, team deserves credit for inventing the gene-editing technique.